Limitations of proficiency testing under CLIA '67.

Area of Science:

• Clinical Laboratory Science
• Health Services Research
• Regulatory Affairs

Background:

• Proficiency testing (PT) is a recognized quality assurance and improvement tool in clinical laboratories.
• The Health Care Financing Administration (HCFA) has increasingly used PT as a cornerstone of its regulatory strategy.
• This regulatory use is influenced by the Clinical Laboratory Improvement Act of 1967 (CLIA '67) and proposed amendments in 1988 (CLIA '88).

Purpose of the Study:

• To explore the limitations of using PT as a primary regulatory tool.
• To analyze the implications of these limitations for clinical laboratories.
• To assess the long-term impact on regulatory PT programs under HCFA and CLIA '88.

Main Methods:

• Analysis of the inherent limitations of PT when employed as a regulatory strategy.
• Examination of the impact on clinical laboratory operations and quality improvement.
• Review of regulatory frameworks including CLIA '67 and CLIA '88.

Main Results:

• Using PT primarily for regulation compromises its effectiveness as a quality improvement tool.
• Significant limitations exist in PT's application as a sole regulatory strategy.
• These limitations have implications for the success of current and future regulatory PT programs.

Conclusions:

• The regulatory use of PT, while intended for quality assurance, has inherent limitations.
• Relying heavily on PT for regulation may hinder its potential for genuine quality improvement in clinical laboratories.
• The effectiveness of CLIA '88 PT programs may be impacted by these identified limitations.